MRSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Marsh & McLennan Companies Inc (MRSH) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's strong financial performance, consistent dividend payouts, positive analyst sentiment, and limited exposure to litigation risks make it an attractive investment opportunity. While there are no immediate trading signals or significant insider/hedge fund activity, the company's growth trajectory and industry position support a long-term buy decision.
No significant stock trend data is available. The pre-market price is $185.29, and the S&P 500 is down 0.24%.
Analysts have upgraded the stock with strong buy ratings and increased price targets, citing consistent margin expansion, AI-related client investments, and the Thrive initiative.
The company has declared a consistent quarterly dividend of $0.90 per share, reflecting shareholder value commitment.
Financials show strong YoY growth in revenue (8.70%), net income (4.19%), and EPS (5.03%) in Q4 2025.
Broader commercial lines margins may face headwinds, particularly in the E&S segment.
No significant insider or hedge fund trading trends to support short-term momentum.
In Q4 2025, revenue increased by 8.70% YoY to $6.595 billion, net income grew by 4.19% YoY to $821 million, and EPS rose by 5.03% YoY to $1.67. Gross margin remained steady at 100%.
Raymond James upgraded the stock to Strong Buy with a price target of $225, citing a high-quality earnings profile and consistent margin expansion. Other firms, including Mizuho and Cantor Fitzgerald, have raised price targets, with targets ranging from $205 to $213, reflecting optimism around the Thrive initiative and cost savings.
